The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic is causing serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further requires the discovery of new therapeutic molecules. BOC Sciences’ Computer-aided drug discovery (CADD) has established itself as a powerful tool.
BOC Sciences highlights two important categories of computer-aided drug discovery (CADD): structured drug discovery. Various techniques involved in structure-based drug design are molecular docking and virtual screening, while ligand-based drug design includes pharmacophore modeling and quantitative structure-activity relationship analysis (QSAR ). More advanced technologies are available at its medicinal chemistry center.
BOC Sciences initiated its research on the Computer-Aided Drug Discovery platform a long time ago, even before the onset of the pandemic. Traditional drug discovery strategies are usually laborious and expensive because the overall process often involves a long cycle and a large number of experiments, in which medical chemists use their experience and intuition to decide on a candidate for development. ulterior. Instead, CADD can be applied as an efficient alternative for the systematic evaluation of potential candidates before they are synthesized and tested. By offering the complete set of CADD services, BOC Sciences can save researchers time and money.
“We are competitive among our peers. Customers vote for us with their continuing contracts,” said BOC Sciences Sales Director, “Our CADD platform has done the work of finding new successes in drug discovery, screening many irrelevant compounds in same time and study the structure-activity relationship of drug molecules faster and cheaper, which is the main driver of our growing popularity. »
He also summarized the key factors contributing to BOC Sciences’ success in CADD development.
- Industry standard software and hardware
- State-of-the-art design concepts and tools
- An experienced scientific team
- Close integration with related disciplines
- Ability to execute patent strategies
BOC Sciences’ CADD has been a success but needs improvement by addressing old challenges and addressing new ones. The interdisciplinary team of chemists, biologists, pharmacologists, toxicologists and microbiologists always works hard to avoid disappointments and maximize productivity at CADD.
BOC Sciences specializes in medicinal chemistry to deal with the design, optimization and development of chemical compounds for use as medicines. He has extensive experience in building screening libraries, lead discovery and optimization, and computational drug discovery.
New York City